PCVX

Vaxcyte Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 3/10
  • Momentum↑ 7/10
Vaxcyte sales and earnings growth
PCVX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -5.22%
  • FCF Y/Y↓ -0.73%
Vaxcyte gross and profit margin trends
PCVX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -22.30%
Vaxcyte net debt vs free cash flow
PCVX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vaxcyte stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗